Robotic neurosurgery is a fast-growing technology owing to several advantages over the traditional neurology surgery such as better outcomes, increased accuracy, sooner recovery, shorter hospital stay among others.
Europe neurosurgical robotics market accounted for $165.6 million in 2020 and will grow by 16.5% annually over 2020-2027 owing to the growing incidents of neurological diseases, aging population, the improved benefits with robotics-based procedures, and decreasing price of robot-assisted neurology surgery.
Highlighted with 44 tables and 37 figures, this 112-page report Europe Neurosurgical Robotics Market 2020-2027 by Product, Equipment Type, End User and Country: Market Size, Share, Forecast and Strategy is based on a comprehensive research of the entire Europe neurosurgical robotics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porters Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe neurosurgical robotics market in every aspect of the classification from perspectives of Product, Equipment Type, End User, and Country.

Based on Product, the Europe market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
Robotic Systems
Instruments and Accessories
System Services

Based on Equipment Type, the Europe market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
Robot Machines
Navigation Systems
Planners and Simulators
Other Equipment Types

Based on End User, the Europe market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
Hospitals
Ambulatory Surgical Centers

Geographically, the following national/local markets are fully investigated:
Germany
UK
France
Spain
Italy
Russia
Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue are available for 2017-2027. The breakdown of key national markets by Product, Equipment Type, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Europe neurosurgical robotics market and industry are assayed quantitatively and qualitatively through GMDs Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Brainlab AG
DePuy Synthes (Johnson & Johnson)
Mazor Robotics Ltd.
Medtronic Inc.
Renishaw plc
Shenzhen Institutes of Advanced Technology (SIAT)
Siemens Healthineers
Simbionix USA Corp.
SONOWAND AS
Stryker Corp. / MAKO
Synaptive Medical, Inc.
Zimmer Biomet Holdings, Inc. / Medtech
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)